Literature DB >> 7769300

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

J M Pawlotsky1, L Tsakiris, F Roudot-Thoraval, C Pellet, L Stuyver, J Duval, D Dhumeaux.   

Abstract

This study examined the relationships between hepatitis C virus (HCV) genotypes and the routes of HCV transmission in 101 patients with chronic hepatitis C. Patients who received blood transfusions (43%) and those with chronic hepatitis C of unknown cause (37%) had similar mean ages, age distribution, and HCV genotype distribution (1a, 19% vs. 14%; 1b, 52% vs. 54%; 3a, 10% vs. 9%; other, 19% vs. 23%). Intravenous drug users (IVDUs) were significantly younger and had a different genotype distribution (1a, 33%; 1b, 0; 3a, 63%; other, 5%; P < .001). Transmission of HCV 3a has been observed only over the past 20 years; other genotypes were transmitted up to 40 years ago. These results suggest that for 20 years there have been two independent ongoing hepatitis C epidemics. One affects persons who received blood transfusions or whose source of infection is unknown. These persons are older and are mainly infected by HCV 1b. The second type of infection occurs in IVDUs and infects younger persons, mainly with HCV 3a.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769300     DOI: 10.1093/infdis/171.6.1607

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  74 in total

1.  Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study.

Authors:  A R Osella; L Sonzogni; A Cavallini; L Foti; V Guerra; A Di Leo; M U Mondelli; G Misciagna; E M Silini
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Phylogenetic characterization of genotype 4 hepatitis C virus isolates from Argentina.

Authors:  V Alfonso; D Flichman; S Sookoian; V A Mbayed; R H Campos
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy.

Authors:  P Dentico; N Curatolo; R Sacco; M De Luca; A Volpe; C Ranieri; C Genchi; L Petracca; R Buongiorno
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

4.  Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Authors:  Matthias Schröter; Bernhard Zöllner; Peter Schäfer; Andreas Reimer; Matthias Müller; Rainer Laufs; Heinz-Hubert Feucht
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

Review 7.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

8.  Clinical relevance of hepatitis C virus genotypes.

Authors:  P Simmonds
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

9.  Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection.

Authors:  M Resti; C Azzari; F Mannelli; M Moriondo; E Novembre; M de Martino; A Vierucci
Journal:  BMJ       Date:  1998-08-15

10.  Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon.

Authors:  Ziyad Mahfoud; Kassem Kassak; Khalil Kreidieh; Sarah Shamra; Sami Ramia
Journal:  Virol J       Date:  2010-05-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.